# Factors that Affect Outcome of Ultrasound-Guided Radiofrequency Ablation of Renal Masses

## TL;DR

This study identifies factors affecting the success of ultrasound-guided radiofrequency ablation for kidney tumors, finding that proximity to the collecting system and ablation temperature are key predictors of residual tumors.

## Contribution

The study identifies specific predictors of residual tumor after ultrasound-guided radiofrequency ablation of renal masses.

## Key findings

- The primary efficacy rate was 79% at 3 months post-ablation.
- Tumor proximity to the collecting system and ablation temperature were significantly associated with residual tumors.
- Ultrasound guidance showed lower efficacy compared to computed tomography guidance in similar studies.

## Abstract

The purpose of this study was to examine the factors influencing the efficacy and safety of the ultrasound-guided radiofrequency ablation of renal tumors. Between January 2010 and December 2018, 159 patients with renal tumors treated with ultrasound-guided percutaneous radiofrequency ablation at our institution were included in this study. Biopsies were performed for histopathological analysis prior to each ablation. Patients underwent computed tomography follow-ups at 3, 6, and 12 months and were subsequently observed on an annual basis. The primary efficacy rate (i.e., residual tumor), local tumor progression, morbidity and mortality, and possible outcome predictors (age, body mass index, gender, tumor size, tumor location, tumor characteristics, ablation temperature, and reported technical problems) were analyzed using binary logistic regression. At the first follow-up, 3 months after ablation, the primary efficacy rate was 79%. Two percent of the tumors showed local tumor progression during the whole follow-up. Tumor proximity to the collecting system and the final temperature in the ablation region were associated with the occurrence of residual tumor (OR = 2.85, p = 0.019 and OR = 4.23, p = 0.006, respectively). A similar trend was shown for tumors larger than 3 cm (p = 0.066). A short distance to the collecting system and the ablation temperature were significantly related to the occurrence of residual tumors after the radiofrequency ablation of small renal masses. The ultrasound guidance used in our study has a lower primary efficacy rate than the computed tomography guidance used in comparable studies.